BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 24519899)

  • 21. Gene-environment interaction and susceptibility in head and neck cancer patients and in their first-degree relatives: a study of Northeast Indian population.
    Choudhury JH; Ghosh SK
    J Oral Pathol Med; 2015 Aug; 44(7):495-501. PubMed ID: 25167831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statistical methods for detecting genetic interactions: a head and neck squamous-cell cancer study.
    Ickstadt K; Schäfer M; Fritsch A; Schwender H; Abel J; Bolt HM; Brüning T; Ko YD; Vetter H; Harth V
    J Toxicol Environ Health A; 2008; 71(11-12):803-15. PubMed ID: 18569579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-nucleotide polymorphisms in DNA double-strand break repair genes: association with head and neck cancer and interaction with tobacco use and alcohol consumption.
    Werbrouck J; De Ruyck K; Duprez F; Van Eijkeren M; Rietzschel E; Bekaert S; Vral A; De Neve W; Thierens H
    Mutat Res; 2008 Oct; 656(1-2):74-81. PubMed ID: 18768166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of glutathione-s-transferase genotypes with environmental risk factors in determining susceptibility to head and neck cancer and treatment response and survival outcome.
    Katiyar T; Yadav V; Maurya SS; Ruwali M; Singh M; Hasan F; Pandey R; Mehrotra D; Singh S; Mishra S; Hadi R; Bhatt MLB; Parmar D
    Environ Mol Mutagen; 2020 Jun; 61(5):574-584. PubMed ID: 32067264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphisms of the glutathione S-transferase P1 gene and head and neck cancer susceptibility.
    Oude Ophuis MB; Roelofs HM; van den Brandt PA; Peters WH; Manni JJ
    Head Neck; 2003 Jan; 25(1):37-43. PubMed ID: 12478542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CYP1A1, GSTM1 and GSTT1 polymorphisms, tobacco and alcohol status and risk of head and neck squamous cell carcinoma.
    Lourenço GJ; Silva EF; Rinck-Junior JA; Chone CT; Lima CS
    Tumour Biol; 2011 Dec; 32(6):1209-15. PubMed ID: 21870186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
    Schneider J; Bernges U; Philipp M; Woitowitz HJ
    Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Combined effects of genetic polymorphisms in cytochrome P450s and GSTM1 on lung cancer susceptibility].
    Gu YF; Zhang ZD; Zhang SC; Zheng SH; Jia HY; Gu SX
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3064-8. PubMed ID: 18261353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator.
    Anantharaman D; Chaubal PM; Kannan S; Bhisey RA; Mahimkar MB
    Carcinogenesis; 2007 Jul; 28(7):1455-62. PubMed ID: 17307803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic polymorphisms of drug-metabolizing enzymes and susceptibility to head-and-neck squamous-cell carcinoma.
    Morita S; Yano M; Tsujinaka T; Akiyama Y; Taniguchi M; Kaneko K; Miki H; Fujii T; Yoshino K; Kusuoka H; Monden M
    Int J Cancer; 1999 Mar; 80(5):685-8. PubMed ID: 10048967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
    Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
    Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined effect of tobacco and DNA repair genes polymorphisms of XRCC1 and XRCC2 influence high risk of head and neck squamous cell carcinoma in northeast Indian population.
    Choudhury JH; Choudhury B; Kundu S; Ghosh SK
    Med Oncol; 2014 Aug; 31(8):67. PubMed ID: 24958516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene-gene interactions of drug metabolizing enzymes and transporter protein in the risk of upper aerodigestive tract cancers among Indians.
    Sam SS; Thomas V; Reddy KS; Surianarayanan G; Chandrasekaran A
    Cancer Epidemiol; 2010 Oct; 34(5):626-33. PubMed ID: 20554493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic polymorphisms of glutathione-S-transferase genes (GSTM1, GSTT1 and GSTP1) and upper aerodigestive tract cancer risk among smokers, tobacco chewers and alcoholics in an Indian population.
    Soya SS; Vinod T; Reddy KS; Gopalakrishnan S; Adithan C
    Eur J Cancer; 2007 Dec; 43(18):2698-706. PubMed ID: 17707637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic polymorphisms of CYP1A1, CYP2E1, GSTM1, and GSTT1 associated with head and neck cancer.
    Gattás GJ; de Carvalho MB; Siraque MS; Curioni OA; Kohler P; Eluf-Neto J; Wünsch-Filho V
    Head Neck; 2006 Sep; 28(9):819-26. PubMed ID: 16721740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic Phase I (CYPs) and Phase II (GSTs) Gene Polymorphisms and Their Interaction with Environmental Factors in Nasopharyngeal Cancer from the Ethnic Population of Northeast India.
    Singh SA; Ghosh SK
    Pathol Oncol Res; 2019 Jan; 25(1):33-44. PubMed ID: 28952035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferases M1, T1, and P1 on susceptibility to esophageal cancer among high-risk individuals in China.
    Tan W; Song N; Wang GQ; Liu Q; Tang HJ; Kadlubar FF; Lin DX
    Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):551-6. PubMed ID: 10868687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic polymorphism of drug metabolizing enzymes (GSTM1 and CYP1A1) as risk factors for oral premalignant lesions and oral cancer.
    Shukla D; Dinesh Kale A; Hallikerimath S; Vivekanandhan S; Venkatakanthaiah Y
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2012 Sep; 156(3):253-9. PubMed ID: 22660220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of drug metabolizing cytochrome P450 2D6 poor metabolizers with cytochrome P450 2C9 and 2C19 genotypes modify the susceptibility to head and neck cancer and treatment response.
    Yadav SS; Ruwali M; Pant MC; Shukla P; Singh RL; Parmar D
    Mutat Res; 2010 Feb; 684(1-2):49-55. PubMed ID: 19954746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CYP1A1, CYP2E1, GSTM1, GSTT1, EPHX1 exons 3 and 4, and NAT2 polymorphisms, smoking, consumption of alcohol and fruit and vegetables and risk of head and neck cancer.
    Boccia S; Cadoni G; Sayed-Tabatabaei FA; Volante M; Arzani D; De Lauretis A; Cattel C; Almadori G; van Duijn CM; Paludetti G; Ricciardi G
    J Cancer Res Clin Oncol; 2008 Jan; 134(1):93-100. PubMed ID: 17611777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.